A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
This report aims to provide a comprehensive presentation of the global market for T-Cell & NK-Cell Engaging Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell & NK-Cell Engaging Bispecific Antibodies. This report contains market size and forecasts of T-Cell & NK-Cell Engaging Bispecific Antibodies in global, including the following market information:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales, 2018-2023, 2024-2029, (ml)
Global top five T-Cell & NK-Cell Engaging Bispecific Antibodies companies in 2022 (%)
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market was valued at US$ 485.7 million in 2022 and is projected to reach US$ 608.1 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (ml)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Type, 2022 (%)
Recombinant Monoclonal Antibodies
In-House Bispecific Antibodies
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (ml)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Application, 2022 (%)
Immunotherapy of Cancer
Clinical Experiment
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (ml)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues share in global market, 2022 (%)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales in global market, 2018-2023 (Estimated), (ml)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Astellas Pharma
GEMoaB Monoclonals
Immunocore
Molecular Partners
Roche
AstraZeneca
Merck & Co.
Pfizer
Eli Lilly
IGM Biosciences
Novartis
BenHealth Biopharmaceuticals
CytomX Therapeutics
Janssen
Lava Therapeutics
MacroGenics
Maverick Therapeutics
VBL Therapeutics
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of T-Cell & NK-Cell Engaging Bispecific Antibodies, market overview.
Chapter 2: Global T-Cell & NK-Cell Engaging Bispecific Antibodies market size in revenue and volume.
Chapter 3: Detailed analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T-Cell & NK-Cell Engaging Bispecific Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global T-Cell & NK-Cell Engaging Bispecific Antibodies capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Overall Market Size
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2022 VS 2029
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, Prospects & Forecasts: 2018-2029
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales: 2018-2029
3 Company Landscape
3.1 Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.2 Top Global T-Cell & NK-Cell Engaging Bispecific Antibodies Companies Ranked by Revenue
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies
3.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies
3.5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.8.1 List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Markets, 2022 & 2029
4.1.2 Recombinant Monoclonal Antibodies
4.1.3 In-House Bispecific Antibodies
4.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
4.2.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2023
4.2.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2024-2029
4.2.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
4.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
4.3.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2023
4.3.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2024-2029
4.3.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
4.4 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2022 & 2029
5.1.2 Immunotherapy of Cancer
5.1.3 Clinical Experiment
5.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
5.2.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2023
5.2.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2024-2029
5.2.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
5.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
5.3.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2023
5.3.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2024-2029
5.3.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
5.4 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2022 & 2029
6.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
6.2.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2023
6.2.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2024-2029
6.2.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
6.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
6.3.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2023
6.3.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2024-2029
6.3.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.4.2 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.4.3 US T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.4.4 Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.4.5 Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.5.2 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.5.3 Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.4 France T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.5 U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.6 Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.7 Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.8 Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.9 Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.6.2 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.6.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.4 Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.5 South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.6 Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.7 India T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.7.2 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.7.3 Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.7.4 Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.8.3 Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8.4 Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8.5 Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8.6 UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.1.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.2.4 Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 GEMoaB Monoclonals
7.3.1 GEMoaB Monoclonals Company Summary
7.3.2 GEMoaB Monoclonals Business Overview
7.3.3 GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.3.4 GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.3.5 GEMoaB Monoclonals Key News & Latest Developments
7.4 Immunocore
7.4.1 Immunocore Company Summary
7.4.2 Immunocore Business Overview
7.4.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.4.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.4.5 Immunocore Key News & Latest Developments
7.5 Molecular Partners
7.5.1 Molecular Partners Company Summary
7.5.2 Molecular Partners Business Overview
7.5.3 Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.5.4 Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.5.5 Molecular Partners Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.6.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.7.4 AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Merck & Co.
7.8.1 Merck & Co. Company Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.8.4 Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.8.5 Merck & Co. Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.9.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.10.4 Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 IGM Biosciences
7.11.1 IGM Biosciences Company Summary
7.11.2 IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Business Overview
7.11.3 IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.11.4 IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.11.5 IGM Biosciences Key News & Latest Developments
7.12 Novartis
7.12.1 Novartis Company Summary
7.12.2 Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Business Overview
7.12.3 Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.12.4 Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.12.5 Novartis Key News & Latest Developments
7.13 BenHealth Biopharmaceuticals
7.13.1 BenHealth Biopharmaceuticals Company Summary
7.13.2 BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Business Overview
7.13.3 BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.13.4 BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.13.5 BenHealth Biopharmaceuticals Key News & Latest Developments
7.14 CytomX Therapeutics
7.14.1 CytomX Therapeutics Company Summary
7.14.2 CytomX Therapeutics Business Overview
7.14.3 CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.14.4 CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.14.5 CytomX Therapeutics Key News & Latest Developments
7.15 Janssen
7.15.1 Janssen Company Summary
7.15.2 Janssen Business Overview
7.15.3 Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.15.4 Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.15.5 Janssen Key News & Latest Developments
7.16 Lava Therapeutics
7.16.1 Lava Therapeutics Company Summary
7.16.2 Lava Therapeutics Business Overview
7.16.3 Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.16.4 Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.16.5 Lava Therapeutics Key News & Latest Developments
7.17 MacroGenics
7.17.1 MacroGenics Company Summary
7.17.2 MacroGenics Business Overview
7.17.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.17.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.17.5 MacroGenics Key News & Latest Developments
7.18 Maverick Therapeutics
7.18.1 Maverick Therapeutics Company Summary
7.18.2 Maverick Therapeutics Business Overview
7.18.3 Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.18.4 Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.18.5 Maverick Therapeutics Key News & Latest Developments
7.19 VBL Therapeutics
7.19.1 VBL Therapeutics Company Summary
7.19.2 VBL Therapeutics Business Overview
7.19.3 VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.19.4 VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.19.5 VBL Therapeutics Key News & Latest Developments
7.20 Amgen
7.20.1 Amgen Company Summary
7.20.2 Amgen Business Overview
7.20.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.20.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.20.5 Amgen Key News & Latest Developments
8 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity, Analysis
8.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity, 2018-2029
8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 T-Cell & NK-Cell Engaging Bispecific Antibodies Supply Chain Analysis
10.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
10.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Upstream Market
10.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies in Global Market
Table 2. Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market, Ranking by Revenue (2022)
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Companies, 2018-2023
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies, (ml), 2018-2023
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Price (2018-2023) & (US$/ml)
Table 8. Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
Table 9. List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2018-2023
Table 15. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2024-2029
Table 16. By Application ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2018-2023
Table 20. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2024-2029
Table 21. By Region ? Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2018-2023
Table 25. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), 2024-2029
Table 26. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 29. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 30. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 33. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 34. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 37. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 41. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2018-2023
Table 45. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (ml), 2024-2029
Table 46. AbbVie Company Summary
Table 47. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 48. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Astellas Pharma Company Summary
Table 51. Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 52. Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 53. Astellas Pharma Key News & Latest Developments
Table 54. GEMoaB Monoclonals Company Summary
Table 55. GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 56. GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 57. GEMoaB Monoclonals Key News & Latest Developments
Table 58. Immunocore Company Summary
Table 59. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 60. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 61. Immunocore Key News & Latest Developments
Table 62. Molecular Partners Company Summary
Table 63. Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 64. Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 65. Molecular Partners Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 68. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 72. AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. Merck & Co. Company Summary
Table 75. Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 76. Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 77. Merck & Co. Key News & Latest Developments
Table 78. Pfizer Company Summary
Table 79. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 80. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 81. Pfizer Key News & Latest Developments
Table 82. Eli Lilly Company Summary
Table 83. Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 84. Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 85. Eli Lilly Key News & Latest Developments
Table 86. IGM Biosciences Company Summary
Table 87. IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 88. IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 89. IGM Biosciences Key News & Latest Developments
Table 90. Novartis Company Summary
Table 91. Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 92. Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 93. Novartis Key News & Latest Developments
Table 94. BenHealth Biopharmaceuticals Company Summary
Table 95. BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 96. BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 97. BenHealth Biopharmaceuticals Key News & Latest Developments
Table 98. CytomX Therapeutics Company Summary
Table 99. CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 100. CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 101. CytomX Therapeutics Key News & Latest Developments
Table 102. Janssen Company Summary
Table 103. Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 104. Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 105. Janssen Key News & Latest Developments
Table 106. Lava Therapeutics Company Summary
Table 107. Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 108. Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 109. Lava Therapeutics Key News & Latest Developments
Table 110. MacroGenics Company Summary
Table 111. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 112. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 113. MacroGenics Key News & Latest Developments
Table 114. Maverick Therapeutics Company Summary
Table 115. Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 116. Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 117. Maverick Therapeutics Key News & Latest Developments
Table 118. VBL Therapeutics Company Summary
Table 119. VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 120. VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 121. VBL Therapeutics Key News & Latest Developments
Table 122. Amgen Company Summary
Table 123. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 124. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (ml), Revenue (US$, Mn) and Average Price (US$/ml) (2018-2023)
Table 125. Amgen Key News & Latest Developments
Table 126. T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (ml) of Key Manufacturers in Global Market, 2021-2023 (ml)
Table 127. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2018-2023 (ml)
Table 129. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2024-2029 (ml)
Table 130. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Opportunities & Trends in Global Market
Table 131. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers in Global Market
Table 132. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints in Global Market
Table 133. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials
Table 134. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials Suppliers in Global Market
Table 135. Typical T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream
Table 136. T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Clients in Global Market
Table 137. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global Market
List of Figures
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type in 2022
Figure 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application in 2022
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029 (US$, Mn)
Figure 7. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Global Market: 2018-2029 (ml)
Figure 8. The Top 3 and 5 Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2022
Figure 9. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 11. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/ml), 2018-2029
Figure 13. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 15. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 16. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/ml), 2018-2029
Figure 17. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 20. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 21. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 22. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 23. US T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 24. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 27. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 28. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 29. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 31. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 32. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 37. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 38. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 41. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 43. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 44. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
Figure 48. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 49. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 51. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2018-2029
Figure 52. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (ml), 2018-2029
Figure 53. The Percentage of Production T-Cell & NK-Cell Engaging Bispecific Antibodies by Region, 2022 VS 2029
Figure 54. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
Figure 55. Marketing Channels
